ARCHIVES

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

This article is from The Cancer Letter archive.

Vol. 15 No. 04 | January 27, 1989

Download PDF Visit The Full Archive

Related Articles

NCI Director Broder, Going On 3rd Year, Examines Issues Of Funding, Priorities, For Institute’s Future

September 20, 1991

NCI Programs: Institute To Develop Plans For Large Trial Of Spiral CT Scanning For Lung Cancer

November 5, 1999

Tuck To Direct Clinical Trials At Yale; Arceci Joins Hopkins.

October 13, 2000

Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol

March 5, 1999

NCI Says. President Bush Visits NIH, Marks Decline In U.S. Cancer Deaths For Second Year.

January 19, 2007

AACR President: Cancer Program ‘Threatened,’ Calls For Strategic Plan, More Extramural Input

December 6, 1991